Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 14, 2022 11:46am
Thinking Out Loud
some thoughts about the flip flop. in the Q1 financials aug/15 they talked about how excited they were about there progress and the launch of the P2 molar study which was to begin end of sep
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 14, 2022 7:45am
Junk Stocks
are like magnets to the trash posters bolth bashers and pumptards, when a stock is 70% bashers it is a good idea to stay away from, that means there are only a few investors left that did not get out
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 13, 2022 11:11pm
-----
https://scitechdaily.com/nanoparticle-probiotic-backpacks-show-promise-for-treating-inflammatory-bowel-diseases-like-crohns-and-ulcerative-colitis/
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 12, 2022 10:24pm
Pez...next week will be a new 52 week low
maybe Wally will sell some shares for christmas presents. Nothing would suprise me aT this point. Good luck everyone. =)
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 11, 2022 12:25pm
I picked up
a few more shares earlier today @47, just in case there will be some stock price moving news next week. canceling that 49 cent order turned out to be a good idea.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Nov 11, 2022 9:41am
Next Week's Financials and Update ...
Wonder if an IBD patent has dropped so they can discuss the first IBD direction next week. Any Chronic updates would also be well received (by me). : )
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 09, 2022 8:44pm
Lol
Pez ...you so dumb. See you in tbe .30's muffin
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 09, 2022 10:22am
Hey davgro, mugs has some land for sale in florida
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 08, 2022 11:41pm
;-)
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 08, 2022 11:40pm
Pez
i missed you buddy. Glad you are doing fine. Say whats you average now? Im sure its .48 cents like the rest of the pumper clown crew. Im going to buy a little at 30 cents. After the recession is in
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Nov 08, 2022 5:50pm
RE:Pain Relief Product Branding
Well that image didn't post properly. Let's try this once more.
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Nov 08, 2022 5:46pm
Pain Relief Product Branding
I wonder if Novartis got this branding idea from posts on their Stockhouse NVS bullboard ?? ATB-352 R----d So what do you think for our possible retail product branding ? [img]https://res
...more
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Nov 08, 2022 5:05pm
RE:RE:Did you get the rest of your fill Davgro ?
Yea why did they get rid of the all or none orders? Dumb move...dare I say a retarded move lol!
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 08, 2022 4:46pm
RE:RE:Did you get the rest of your fill Davgro ?
Ya - that's a good way to look at it.
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Nov 08, 2022 4:23pm
RE:Did you get the rest of your fill Davgro ?
I got another 1000 shares just before the close for a total of 9,500 of my original 20,000 share order. Its frustratating that TD charges me $7 commission for a $480 fill but ever since they removed
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >